I6T-MC-AMAP - ClinicalTrials.gov - NCT03519945
I6T-MC-AMAP - ClinicalTrials.gov - NCT03519945
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed Studies AMAC (NCT02589665) or AMBG (NCT03524092), received study drug, and did not stop study drug early - Female participants must agree to contraception requirements
Participants must NOT
Participants must not have developed a new condition, including cancer, in the originator study
Participants must not have any important infections including, but not limited to, hepatitis B, hepatitis C, HIV/AIDS, and active tuberculosis (TB) during either originator study
Participants must not have received surgery for UC in the originator study and must not be likely to require surgery for treatment of UC during this study
Participants must not have developed growths, known as polyps, that develop on the lining of the large intestine during the originator study that have not been removed prior to the start of this study
Trial Summary
Conditions the trial is for
Ulcerative Colitis
What the trial is testing?
Mirikizumab
Could I receive a Placebo?
no
Enrollment Goal
840
Trial Dates
July 2018 - July 2025
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed Studies AMAC (NCT02589665) or AMBG (NCT03524092), received study drug, and did not stop study drug early - Female participants must agree to contraception requirements
Participants must NOT
Participants must not have developed a new condition, including cancer, in the originator study
Participants must not have any important infections including, but not limited to, hepatitis B, hepatitis C, HIV/AIDS, and active tuberculosis (TB) during either originator study
Participants must not have received surgery for UC in the originator study and must not be likely to require surgery for treatment of UC during this study
Participants must not have developed growths, known as polyps, that develop on the lining of the large intestine during the originator study that have not been removed prior to the start of this study
Trial Summary
Conditions the trial is for
Ulcerative Colitis
What the trial is testing?
Mirikizumab
Could I receive a Placebo?
no
Enrollment Goal
840
Trial Dates
July 2018 - July 2025
Trial Phase
3
Trial Locations
Hide locations not currently recruiting